Dotarem®
DGD-44-058
Approved small_molecule completed
Quick answer
Dotarem® for Primary Brain Tumor is a Approved program (small_molecule) at Guerbet with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Guerbet
- Indication
- Primary Brain Tumor
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed